We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validation of an Urticaria Control Test (UCT-V)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01614834
First Posted: June 8, 2012
Last Update Posted: January 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany
  Purpose
The aim of this study is to validate a previously developed patient reported outcome instrument (in project UCT-D) to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Condition
Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Development (and Validation) of an Instrument to Assess Disease Control in Patients With Urticaria (Urticaria Control Test)

Resource links provided by NLM:


Further study details as provided by K. Weller, Charite University, Berlin, Germany:

Enrollment: 120
Study Start Date: July 2012
Study Completion Date: September 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic urticaria patients
all patients suffering from chronic forms of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients suffering from chronic forms of urticaria
Criteria
all patients suffering from chronic forms of urticaria are eligible
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01614834


Locations
Germany
Universitätshautklinik Mainz
Mainz, Rheinland-Pfalz, Germany, 55131
Allergie-Centrum-Charite
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

Responsible Party: K. Weller, Pricipal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01614834     History of Changes
Other Study ID Numbers: UCT-V
First Submitted: June 6, 2012
First Posted: June 8, 2012
Last Update Posted: January 6, 2017
Last Verified: January 2017

Keywords provided by K. Weller, Charite University, Berlin, Germany:
urticaria
disease control
severity
test

Additional relevant MeSH terms:
Urticaria
Skin Diseases, Vascular
Skin Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases